首页> 外文期刊>Current molecular imaging >In vivo Optical Molecular Imaging of Cardiovascular Diseases: Long Road Ahead
【24h】

In vivo Optical Molecular Imaging of Cardiovascular Diseases: Long Road Ahead

机译:心血管疾病的体内光学分子成像:任重而道远

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Optical molecular imaging is a powerful imaging method, which can in vivo monitor physiological and patho-biological processes at the cellular and molecular levels, as opposed to the anatomical level, bridging the gap between imaging and biological processes. Because of its relevance in cardiovascular diseases research, the use of this technology for imaging of cardiovascular diseases advances at a rapid pace in the past decade. This review summarizes the optical molecular imaging methods for imaging the specific targets in cardiovascular diseases, which hold promise for in vivo applications in cardiovascular diseases research. Collectively, in vivo optical molecular imaging may be highly suitable for discriminating targets that play key roles in the occurrence and development of the instable atherosclerosis, thrombogenesis, myocardial infarction, myocardial apoptosis, angiogenesis, as well as in cardiac cell transplantation.
机译:光学分子成像是一种强大的成像方法,可以在体内和细胞水平上而不是在解剖学水平上监测生理和病理生物学过程,从而弥合了成像和生物学过程之间的空白。由于其在心血管疾病研究中的重要性,在过去十年中,该技术在心血管疾病成像中的应用正在迅速发展。这篇综述总结了用于对心血管疾病中的特定靶标进行成像的光学分子成像方法,这为在心血管疾病研究中的体内应用提供了希望。总体而言,体内光学分子成像可能非常适用于区分在不稳定的动脉粥样硬化,血栓形成,心肌梗塞,心肌细胞凋亡,血管生成以及在心脏细胞移植中的发生和发展中起关键作用的靶标。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号